HR 810 109th Congress House Health Administrative procedure Congress Congressional reporting requirements Cytology Department of Health and Human Services Donation of organs, tissues, etc. Economics and Public Finance Federal aid to research Genetic research Genetics Government Operations and Politics Human embryology In vitro fertilization Informed consent (Medical law) Law Medical ethics Medical research Research grants Science, Technology, Communications

Stem Cell Research Enhancement Act of 2005

Introduced: February 15, 2005 See on congress.gov

Everywhere this bill has been 25 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jul 19, 2006

On motion to refer the bill and the accompanying veto message to the Committee on Energy and Commerce. Agreed to without objection.

Jul 19, 2006

Motion to refer the bill and accompanying veto message to the Committee on Energy and Commerce.

Jul 19, 2006

On passage, the objections of the President to the contrary notwithstanding Failed by the Yeas and Nays: (2/3 required): 235 - 193 (Roll no. 388). (consideration: CR H5435-5451)

Jul 19, 2006

Failed of passage in House over veto: On passage, the objections of the President to the contrary notwithstanding Failed by the Yeas and Nays: (2/3 required): 235 - 193 (Roll no. 388).(consideration: CR H5435-5451)

Jul 19, 2006

DEBATE - The House proceeded with one hour of debate on the question of passage of H.R. 810, the objections of the President to the contrary, notwithstanding.

Jul 19, 2006

The Chair laid before the House the veto message from the President.

Jul 19, 2006

Vetoed by President. (text of veto message: CR H5435)

Jul 19, 2006

Vetoed by President.(text of veto message: CR H5435)

Jul 19, 2006

Presented to President.

Jul 18, 2006

Message on Senate action sent to the House.

Jul 18, 2006

Passed Senate without amendment by Yea-Nay Vote. 63 - 37. Record Vote Number: 206.

Jul 18, 2006

Passed/agreed to in Senate: Passed Senate without amendment by Yea-Nay Vote. 63 - 37. Record Vote Number: 206.

Jul 18, 2006

Considered by Senate. (consideration: CR S7654-7692)

Jul 17, 2006

Measure laid before Senate by unanimous consent. (consideration: CR S7569-7623)

Jun 6, 2005

Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 119.

May 26, 2005

Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.

May 24, 2005

Motion to reconsider laid on the table Agreed to without objection.

May 24, 2005

On passage Passed by the Yeas and Nays: 238 - 194 (Roll no. 204). (text: CR H3809)

May 24, 2005

Passed/agreed to in House: On passage Passed by the Yeas and Nays: 238 - 194 (Roll no. 204).(text: CR H3809)

May 24, 2005

The previous question was ordered pursuant to a previous order of the House. (consideration: CR H3851)

May 24, 2005

DEBATE - Pursuant to a previous order, the House proceeded with 3 hours of general debate on H.R. 810.

May 24, 2005

Considered pursuant to a previous order. (consideration: CR H3809-3853)

May 24, 2005

Consideration initiated pursuant to a previous order.

Feb 15, 2005

Referred to the House Committee on Energy and Commerce.

Feb 15, 2005

Introduced in House

Votes taken on this bill 2

Date	Chamber	What was voted on	Result	Yes–No
Jul 19, 2006	House · vote #388	Passage, Objections of the President Not Withstanding	Failed	235–193	See who voted →
May 24, 2005	House · vote #204	On Passage	Passed	238–194	See who voted →

Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The expanded summary of the House passed version is repeated here.)

Stem Cell Research Enhancement Act of 2005 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo, provided such embryos: (1) have been donated from in vitro fertilization clinics; (2) were created for the purposes of fertility treatment; (3) were in excess of the needs of the individuals seeking such treatment and would never be implanted in a woman and would otherwise be discarded (as determined in consultation with the individuals seeking fertility treatment); and (4) were donated by such individuals with written informed consent and without any financial or other inducements.

Requires the Secretary to: (1) issue final guidelines to carry out this Act within 60 days; and (2) submit annual reports on activities and research conducted under this Act.

What's happening now July 19, 2006

On motion to refer the bill and the accompanying veto message to the Committee on Energy and Commerce. Agreed to without objection.

Committees of jurisdiction 1